Open tender · Germany · Pharmaceutical products
Open house Arzneimittelrabattverträge zum Wirkstoff Ublituximab, ATC L04AG14
In EnglishOpen house drug discount agreements for the active substance Ublituximab, ATC L04AG14
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse in Germany is inviting bids for “Open house drug discount agreements for the active substance Ublituximab, ATC L04AG14”. Bids close on 28 February 2027, 23:59 CET. askTender lists every requirement to qualify and checks whether your company meets them.
Key facts
- Procedure
- Contract notice
Before you bid, askTender
Everything else is in your askTender account
The requirements to qualify, the eligibility check and the bid documents for this tender are in your askTender account.
- What it takes to qualify: every requirement, in the tender’s own words
- Whether your company qualifies: your profile checked against each requirement, showing what you have, what’s missing and how to close the gap
- The documents to file: a checklist, with draft declarations ready to sign
- A bid partner for any requirement you can’t meet alone
- Alerts for new tenders like this one
Public data: TED – Tenders Electronic Daily. © European Union, 1998–2026. Notices reused under Commission Decision 2011/833/EU. · Sources & licences